Monsanto Announces Second-Quarter Financial Results in Line with Mid-Teens Earnings Growth Opportunity
Company Confirms Full-Year Ongoing Earnings Per Share Guidance, Raises Free Cash Flow Expectation
ST. LOUIS, April 6, 2011 /PRNewswire/ -- With half its fiscal year complete, Monsanto Company (NYSE: MON) today said a solid sales season for its U.S. seeds and traits business and disciplined approach to spending have positioned the company to realize its mid-teens earnings growth opportunity this year and set a strong foundation for coming seasons. In reporting its earnings results for the quarter ending Feb. 28, 2011, the company highlighted performance tracking with projections in both the seeds and genomics and agricultural productivity segments that affirms its full-year ongoing earnings per share guidance. The company also increased its free cash flow guidance for the full-year, driven by better than expected working-capital management and a strong economic climate in agriculture.
Second Quarter | Six Months | ||||||||||||
($ in millions) | 2011 | 2010 | 2011 | 2010 | |||||||||
Net Sales By Segment | |||||||||||||
Corn seed and traits | $ | 2,397 | $ | 2,247 | $ | 3,011 | $ | 2,816 | |||||
Soybean seed and traits | 615 | 633 | 841 | 834 | |||||||||
Cotton seeds and traits | 67 | 34 | 179 | 93 | |||||||||
Vegetable seeds | 229 | 223 | 412 | 396 | |||||||||
All other crops seeds and traits | 113 | 111 | 141 | 140 | |||||||||
TOTAL Seeds and Genomics | $ | 3,421 | $ | 3,248 | $ | 4,584 | $ | 4,279 | |||||
Agricultural productivity | $ | 708 | $ | 642 | $ | 1,375 | $ | 1,308 | |||||
TOTAL Agricultural Productivity | $ | 708 | $ | 642 | $ | 1,375 | $ | 1,308 | |||||
TOTAL Net Sales | $ | 4,129 | $ | 3,890 | $ | 5,959 | $ | 5,587 | |||||
Gross Profit | $ | 2,308 | $ | 2,099 | $ | 3,126 | $ | 2,838 | |||||
Operating Expenses | $ | 823 | $ | 821 | $ | 1,583 | $ | 1,598 | |||||
Interest Expense – Net | $ | 20 | $ | 27 | $ | 48 | $ | 55 | |||||
Other Expense (Income) – Net | $ | 11 | $ | 2 | $ | 23 | $ | (10) | |||||
Net Income Attributable to Monsanto Company | $ | 1,017 | $ | 887 | $ | 1,023 | $ | 868 | |||||
Diluted Earnings per Share (See note 1.) | $ | 1.88 | $ | 1.60 | $ | 1.88 | $ | 1.57 | |||||
Items Affecting Comparability – EPS Impact | |||||||||||||
Restructuring charges | — | 0.10 | 0.01 | 0.12 | |||||||||
Income on discontinued operations | (0.01) | — | — | (0.01) | |||||||||
Diluted Earnings per Share from Ongoing Business (For the definition of ongoing EPS, see note 1.) | $ | 1.87 | $ | 1.70 | $ | 1.89 | $ | 1.68 | |||||
Effective Tax Rate | 29% | 29% | 29% | 28% | |||||||||
Second Quarter | Six Months | ||||||||
Comparison as a Percent of Net Sales: | 2011 | 2010 | 2011 | 2010 | |||||
Gross profit | 56% | 54% | 52% | 51% | |||||
Selling, general and administrative expenses (SG&A) | 12% | 13% | 16% | 18% | |||||
Research and development expenses | 8% | 7% | 10% | 10% | |||||
Income from continuing operations before income taxes | 35% | 32% | 25% | 21% | |||||
Net income attributable to Monsanto Company | 25% | 23% | 17% | 16% | |||||
"We came into this year with an operational plan built around creating value for our customers," said Hugh Grant, chairman, president and chief executive officer for Monsanto. "It was a plan that was designed for balanced growth – across crops, across geographies and through a combination of mix and volume improvements. We exist to serve our farmer customers, and it is rewarding to see this plan is resonating with them. Given the tempo of the year, we are where we should be, and we have the right pieces and the right execution to feel very good that mid-teens earnings growth in 2011 is on track."
Results of Operations
Net sales increased $239 million, or 6 percent, in the three-month comparison driven by volume in both the seeds and genomics and agricultural productivity segments. Net income in the second quarter was $1 billion.
Gross profit rose 10 percent in the quarter to $2.3 billion, with margins higher due to cost improvements. For the first six months, gross profit is up 10 percent or $288 million.
Operating expenses were up $2 million in the second quarter compared to the prior year. In the three-month comparison, selling, general and administrative (SG&A) expenses decreased 2 percent. R&D expenses increased as the company continues to manage more projects in advanced pipeline phases.
Earnings per share (EPS) for the second quarter was $1.88 on an as-reported basis, and $1.87 on an ongoing basis. EPS for the first six months of fiscal year 2011 was $1.88 on an as-reported basis, and $1.89 on an ongoing basis. (For a reconciliation of EPS to ongoing EPS see page 1).
Cash Flow
The second quarter saw a continuation of the strong start to the year. For the first half of fiscal year 2011, cash flow from operations was a source of $1.4 billion compared to $256 million in the first half last year. Net cash required by investing activities for the first half of fiscal year 2011 was $524 million, compared to $345 million for the same period of fiscal year 2010.
Net cash required by financing activities for the first half of 2011 was $668 million, compared to net cash required of $259 million for the same period of fiscal year 2010. The company continues to make progress on its current $1 billion, three-year share repurchase authorization, spending $114 million on repurchases in the second quarter for a total purchase of $381 million for the first half of the fiscal year.
Free cash flow was a source of $917 million for the first half of fiscal year 2011, compared to a use of $89 million for the first half of fiscal year 2010. (For a reconciliation of free cash flow, see note 1.)
Outlook
The company affirmed its previously announced ongoing EPS guidance and raised its full-year free cash flow guidance for fiscal year 2011 to the range of $900 million to $1.1 billion. The company expects net cash provided by operating activities to be $1.8 billion to $2.1 billion, and net cash required by investing activities to be approximately $900 million to $1 billion for fiscal year 2011. (For a reconciliation of free cash flow, see note 1.)
The company confirmed full-year 2011 ongoing EPS guidance is in the range of $2.72 to $2.82. Full-year 2011 EPS guidance on an as-reported basis is in the range of $2.66 to $2.79. (For a reconciliation of EPS, see note 1.)
Seeds and Genomics Segment Detail | |||||||||||||||||||
($ in millions) | Net Sales | Gross Profit | |||||||||||||||||
Second Quarter | Six Months | Second Quarter | Six Months | ||||||||||||||||
Seeds and Genomics | 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | |||||||||||
Corn Seed and Traits | $ | 2,397 | $ | 2,247 | $ | 3,011 | $ | 2,816 | $ | 1,506 | $ | 1,420 | $ | 1,845 | $ | 1,724 | |||
Soybean Seed and Traits | 615 | 633 | 841 | 834 | 414 | 386 | 567 | 525 | |||||||||||
Cotton Seed and Traits | 67 | 34 | 179 | 93 | 42 | 15 | 116 | 48 | |||||||||||
Vegetable Seeds | 229 | 223 | 412 | 396 | 125 | 138 | 238 | 250 | |||||||||||
All Other Crops Seeds and Traits | 113 | 111 | 141 | 140 | 44 | 53 | 44 | 62 | |||||||||||
TOTAL Seeds and Genomics | $ | 3,421 | $ | 3,248 | $ | 4,584 | $ | 4,279 | $ | 2,131 | $ | 2,012 | $ | 2,810 | $ | 2,609 | |||
($ in millions) | Earnings (Loss) Before Interest & Taxes (EBIT) | |||||||||||
Second Quarter | Six Months | |||||||||||
Seeds and Genomics | 2011 | 2010 | 2011 | 2010 | ||||||||
EBIT (For a reconciliation of EBIT, see note 1.) | $ | 1,403 | $ | 1,362 | $ | 1,383 | $ | 1,305 | ||||
Unusual Items Affecting EBIT: Restructuring | $ | (3) | $ | (59) | $ | (14) | $ | (62) | ||||
The Seeds and Genomics segment consists of the company's global seeds and related traits business.
In total, sales for Monsanto's Seeds and Genomics segment in the second quarter of fiscal 2011 increased 5 percent or $173 million, driven by global unit volume growth and a mix upgrade in the United States.
While it's early in the season, the company indicated sales are pacing to meet the mid-teens millions of U.S. acres it had expected for both its Genuity® Roundup Ready 2 Yield® soybeans and the Genuity® reduced refuge corn family this year. This brings a positive mix improvement across Monsanto's U.S. soybean and corn portfolios.
Globally, the company saw higher branded corn sales in Brazil, the United States and Europe in the quarter. In U.S. corn, the company has made significant product and pricing strategy moves, identifying lead products in each of the major geographies while making all products available across areas to meet farmers' needs. Genuity® SmartStax®, which provides the broadest spectrum of insect and weed control, is receiving strong interest in heavy rootworm areas of the Northern Corn Belt. Genuity® VT Triple PRO® and Genuity® VT Double PRO® are complementing the Genuity® SmartStax® build-out, with Genuity® VT Triple PRO® generating strong interest in the South as Genuity® VT Double PRO® does the same in areas with an established doubles market.
The cotton business also is performing well this year, with mix and volume improvements led by second-generation trait offerings and continued breeding gains. The company maintained a positive outlook for vegetables, with the gross profit decline attributed primarily to sales mix timing, which is expected to normalize over the rest of the year.
Agricultural Productivity Segment Detail | |||||||||||||||||
($ in millions) | Net Sales | Gross Profit | |||||||||||||||
Second Quarter | Six Months | Second Quarter | Six Months | ||||||||||||||
2011 | 2010 | 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | ||||||||||
Agricultural Productivity | $ | 708 | $ | 642 | $ | 1,375 | $ | 1,308 | $ | 177 | $ | 87 | $ | 316 | $ | 229 | |
TOTAL Agricultural Productivity | $ | 708 | $ | 642 | $ | 1,375 | $ | 1,308 | $ | 177 | $ | 87 | $ | 316 | $ | 229 | |
($ in millions) | Earnings (Loss) Before Interest & Taxes (EBIT) | ||||||||||||||
Second Quarter | Six Months | ||||||||||||||
Agricultural Productivity | 2011 | 2010 | 2011 | 2010 | |||||||||||
EBIT (For a reconciliation of EBIT, see note 1.) | $ | 60 | $ | (87) | $ | 120 | $ | (53) | |||||||
Unusual Items Affecting EBIT: | |||||||||||||||
EBIT from Discontinued Operations | $ | 4 | $ | — | $ | 4 | $ | 5 | |||||||
Restructuring | $ | — | $ | (25) | $ | 4 | $ | (36) | |||||||
The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products.
Over the last year, the company has made fundamental changes in the crop protection business in particular as it relates to Roundup® and other glyphosate-based herbicides. With this quarter, the structural changes made to this segment are now reflected in the company's financial statements.
In our Agricultural Productivity reportable segment, the company has consolidated the Roundup® and other glyphosate-based herbicides, selective chemistry and lawn-and-garden businesses. The company made this change because the Agricultural Productivity segment now is managed as one business, and the ongoing operations of that business reflect the restructuring that is now complete.
Sales in the second quarter of fiscal 2011 for Monsanto's Agricultural Productivity segment increased 10 percent, with gross profit improvement as well as a function of volume and cost improvements primarily related to production efficiencies following the restructuring.
Webcast Information
In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations and may include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business.
Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at www.monsanto.com and clicking on "Investor Information." Visitors may need to download Windows Media Player™ prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks.
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.
Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.
Notes to editors: Roundup, Genuity, SmartStax and Roundup Ready 2 Yield, VT Triple PRO and VT Double PRO are trademarks of Monsanto Company and its wholly-owned subsidiaries.
References to Roundup herbicides in this release mean Roundup-branded herbicides, excluding lawn-and-garden herbicide products.
Monsanto Company Selected Financial Information (Dollars in millions, except per share amounts) Unaudited | |||||||||||||
Statements of Consolidated Operations | Three Months Ended | Six Months Ended | |||||||||||
Feb. 28, | Feb. 28, | ||||||||||||
2011 | 2010 | 2011 | 2010 | ||||||||||
Net Sales | $ | 4,129 | $ | 3,890 | $ | 5,959 | $ | 5,587 | |||||
Cost of Goods Sold | 1,821 | 1,791 | 2,833 | 2,749 | |||||||||
Gross Profit | 2,308 | 2,099 | 3,126 | 2,838 | |||||||||
Operating Expenses: | |||||||||||||
Selling, general and administrative expenses | 502 | 512 | 952 | 1,008 | |||||||||
Research and development expenses | 320 | 279 | 623 | 546 | |||||||||
Restructuring charges, net | 1 | 30 | 8 | 44 | |||||||||
Total Operating Expenses | 823 | 821 | 1,583 | 1,598 | |||||||||
Income From Operations | 1,485 | 1,278 | 1,543 | 1,240 | |||||||||
Interest Expense | 39 | 41 | 82 | 80 | |||||||||
Interest Income | (19) | (14) | (34) | (25) | |||||||||
Other Expense (Income), Net | 11 | 2 | 23 | (10) | |||||||||
Income from Continuing Operations Before Income Taxes | 1,454 | 1,249 | 1,472 | 1,195 | |||||||||
Income Tax Provision | 428 | 360 | 434 | 330 | |||||||||
Income from Continuing Operations Including Portion | |||||||||||||
Attributable to Noncontrolling Interest | $ | 1,026 | $ | 889 | $ | 1,038 | $ | 865 | |||||
Discontinued Operations: | |||||||||||||
Income from Operations of Discontinued Businesses | 4 | — | 4 | 5 | |||||||||
Income Tax Provision | 1 | — | 1 | — | |||||||||
Income on Discontinued Operations | 3 | — | 3 | 5 | |||||||||
Net Income | $ | 1,029 | $ | 889 | $ | 1,041 | $ | 870 | |||||
Less: Net Income Attributable to Noncontrolling Interest | 12 | 2 | 18 | 2 | |||||||||
Net Income Attributable to Monsanto Company | $ | 1,017 | $ | 887 | $ | 1,023 | $ | 868 | |||||
EBIT (see note 1) | $ | 1,463 | $ | 1,275 | $ | 1,503 | $ | 1,252 | |||||
Basic Earnings per Share Attributable to Monsanto Company: | |||||||||||||
Income from Continuing Operations | $ | 1.89 | $ | 1.63 | $ | 1.90 | $ | 1.58 | |||||
Income on Discontinued Operations | 0.01 | — | — | 0.01 | |||||||||
Net Income Attributable to Monsanto Company | $ | 1.90 | $ | 1.63 | $ | 1.90 | $ | 1.59 | |||||
Diluted Earnings per Share Attributable to Monsanto Company: | |||||||||||||
Income from Continuing Operations | $ | 1.87 | $ | 1.60 | $ | 1.88 | $ | 1.56 | |||||
Income on Discontinued Operations | 0.01 | — | — | 0.01 | |||||||||
Net Income Attributable to Monsanto Company | $ | 1.88 | $ | 1.60 | $ | 1.88 | $ | 1.57 | |||||
Weighted Average Shares Outstanding: | |||||||||||||
Basic | 536.3 | 545.8 | 537.6 | 545.7 | |||||||||
Diluted | 542.4 | 553.4 | 543.7 | 553.4 | |||||||||
Monsanto Company Selected Financial Information (Dollars in millions, except per share amounts) Unaudited | |||||||
Condensed Statements of Consolidated Financial Position | As of | As of | |||||
Feb. 28, 2011 | Aug. 31, 2010 | ||||||
Assets | |||||||
Current Assets: | |||||||
Cash and cash equivalents (variable interest entities restricted - 2011: $13) | $ | 1,837 | $ | 1,485 | |||
Short-term investments | 180 | — | |||||
Trade receivables, net (variable interest entities restricted - 2011: $101) | 2,377 | 1,590 | |||||
Miscellaneous receivables | 620 | 717 | |||||
Deferred tax assets | 451 | 511 | |||||
Inventory, net | 3,090 | 2,739 | |||||
Other current assets | 137 | 80 | |||||
Total Current Assets | 8,692 | 7,122 | |||||
Property, Plant and Equipment, Net | 4,222 | 4,227 | |||||
Goodwill | 3,320 | 3,204 | |||||
Other Intangible Assets, Net | 1,353 | 1,263 | |||||
Noncurrent Deferred Tax Assets | 1,038 | 1,014 | |||||
Long-Term Receivables, Net | 459 | 513 | |||||
Other Assets | 565 | 524 | |||||
Total Assets | $ | 19,649 | $ | 17,867 | |||
Liabilities and Shareowners' Equity | |||||||
Current Liabilities: | |||||||
Short-term debt, including current portion of long-term debt | 409 | 241 | |||||
Accounts payable | 634 | 752 | |||||
Income taxes payable | 284 | 66 | |||||
Accrued compensation and benefits | 258 | 179 | |||||
Accrued marketing programs | 881 | 839 | |||||
Deferred revenues | 919 | 219 | |||||
Grower production accruals | 256 | 130 | |||||
Dividends payable | 150 | 151 | |||||
Customer payable | 3 | 83 | |||||
Restructuring reserves | 59 | 197 | |||||
Miscellaneous short-term accruals | 668 | 684 | |||||
Total Current Liabilities | 4,521 | 3,541 | |||||
Long-Term Debt | 1,729 | 1,862 | |||||
Postretirement Liabilities | 923 | 920 | |||||
Long-Term Deferred Revenue | 375 | 395 | |||||
Noncurrent Deferred Tax Liabilities | 143 | 137 | |||||
Long-Term Portion of Environmental and Litigation Reserves | 179 | 188 | |||||
Other Liabilities | 645 | 681 | |||||
Monsanto Shareowners' Equity | 11,001 | 10,099 | |||||
Noncontrolling Interest | 133 | 44 | |||||
Total Shareowners' Equity | 11,134 | 10,143 | |||||
Total Liabilities and Shareowners' Equity | $ | 19,649 | $ | 17,867 | |||
Debt to Capital Ratio: | 16% | 17% | |||||
Monsanto Company Selected Financial Information (Dollars in millions, except per share amounts) Unaudited | ||||||||
Statements of Consolidated Cash Flows | Six Months Ended Feb. 28, | |||||||
2011 | 2010 | |||||||
Operating Activities: | ||||||||
Net Income | $ | 1,041 | $ | 870 | ||||
Adjustments to reconcile cash provided (required) by operating activities: | ||||||||
Items that did not require (provide) cash: | ||||||||
Depreciation and amortization | 310 | 294 | ||||||
Bad-debt expense | (6) | 26 | ||||||
Stock-based compensation expense | 55 | 52 | ||||||
Excess tax benefits from stock-based compensation | (19) | (31) | ||||||
Deferred income taxes | (13) | (62) | ||||||
Restructuring charges, net | 8 | 44 | ||||||
Equity affiliate income, net | (8) | (18) | ||||||
Net gain on sales of a business or other assets | (4) | (2) | ||||||
Other items | 59 | 38 | ||||||
Changes in assets and liabilities that provided (required) cash, net of acquisitions: | ||||||||
Trade receivables, net | (612) | (459) | ||||||
Inventory, net | (269) | (241) | ||||||
Deferred revenues | 656 | 341 | ||||||
Accounts payable and other accrued liabilities | 507 | (323) | ||||||
Restructuring cash payments | (152) | (124) | ||||||
Pension contributions | (44) | (86) | ||||||
Net investment hedge settlement | — | (4) | ||||||
Other items | (68) | (59) | ||||||
Net Cash Provided by Operating Activities | 1,441 | 256 | ||||||
Cash Flows Required by Investing Activities: | ||||||||
Purchases of short-term investments | (180) | — | ||||||
Capital expenditures | (217) | (342) | ||||||
Acquisitions of businesses, net of cash acquired | (99) | (23) | ||||||
Purchases of long-term equity securities | — | (8) | ||||||
Technology and other investments | (44) | (14) | ||||||
Other investments and property disposal proceeds | 16 | 42 | ||||||
Net Cash Required by Investing Activities | (524) | (345) | ||||||
Cash Flows Required by Financing Activities: | ||||||||
Net change in financing with less than 90-day maturities | (12) | 126 | ||||||
Short-term debt proceeds | 45 | 25 | ||||||
Short-term debt reductions | (27) | (32) | ||||||
Long-term debt reductions | (2) | (1) | ||||||
Payments on other financing | (2) | (1) | ||||||
Treasury stock purchases | (381) | (124) | ||||||
Stock option exercises | 37 | 38 | ||||||
Excess tax benefits from stock-based compensation | 19 | 31 | ||||||
Tax withholding on restricted stock and restricted stock units | (4) | — | ||||||
Dividend payments | (302) | (290) | ||||||
Proceeds from noncontrolling interests | 8 | — | ||||||
Dividend payments to noncontrolling interests | (47) | (31) | ||||||
Net Cash Required by Financing Activities | (668) | (259) | ||||||
Cash Assumed from Initial Consolidations of Variable Interest Entities | 77 | — | ||||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 26 | (1) | ||||||
Net Increase (Decrease) in Cash and Cash Equivalents | 352 | (349) | ||||||
Cash and Cash Equivalents at Beginning of Period | 1,485 | 1,956 | ||||||
Cash and Cash Equivalents at End of Period | $ | 1,837 | $ | 1,607 | ||||
Monsanto Company Selected Financial Information (Dollars in millions) Unaudited | ||
1. | EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP. | |
Reconciliation of EBIT to Net Income (Loss): EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto. | ||
Three Months Ended | Six Months Ended | |||||||||||||
Feb. 28, | Feb. 28, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||
EBIT – Seeds and Genomics Segment | $ | 1,403 | $ | 1,362 | $ | 1,383 | $ | 1,305 | ||||||
EBIT – Agricultural Productivity Segment | 60 | (87) | 120 | (53) | ||||||||||
EBIT– Total | 1,463 | 1,275 | 1,503 | 1,252 | ||||||||||
Interest Expense, Net | 20 | 27 | 48 | 55 | ||||||||||
Income Tax Provision(A) | 426 | 361 | 432 | 329 | ||||||||||
Net Income Attributable to Monsanto Company | $ | 1,017 | $ | 887 | $ | 1,023 | $ | 868 | ||||||
(A) | Includes the income tax provision from continuing operations, the income tax benefit (provision) on noncontrolling interest, and the income tax provision on discontinued operations. | |
Reconciliation of EPS to Ongoing EPS: Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations.
Fiscal Year | Six Months | ||||
2011 | Ended | ||||
Guidance | Feb. 28, 2011 | ||||
Diluted Earnings per Share | $2.66-$2.79 | $1.88 | |||
Restructuring Charges, Net | $0.03 - $0.06 | $0.01 | |||
Income on Discontinued Operations | — | — | |||
Diluted Earnings per Share from Ongoing Business | $2.72-$2.82 | $1.89 | |||
Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2011 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.
Fiscal Year | Six Months Ended | ||||||||
2011 | Feb. 28, | ||||||||
Guidance | 2011 | 2010 | |||||||
Net Cash Provided by Operating Activities | $ | 1,800-2,100 | $ | 1,441 | $ | 256 | |||
Net Cash Required by Investing Activities | (900)-(1,000) | (524) | (345) | ||||||
Free Cash Flow | $ | 900-1,100 | 917 | (89) | |||||
Net Cash Required by Financing Activities | N/A | (668) | (259) | ||||||
Cash Assumed from Initial Consolidations of Variable Interest Entities | N/A | 77 | — | ||||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents | N/A | 26 | (1) | ||||||
Net Increase (Decrease) in Cash and Cash Equivalents | N/A | 352 | (349) | ||||||
Cash and Cash Equivalents at Beginning of Period | N/A | 1,485 | 1,956 | ||||||
Cash and Cash Equivalents at End of Period | N/A | $ | 1,837 | $ | 1,607 | ||||
CONTACT | Media: Kelli Powers (314-694-4003) | |
Analysts: Bryan Hurley (314-694-8148) | ||
SOURCE Monsanto Company
Share this article